Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Cefminox sodium |
EINECS | N/A |
CAS No. | 75498-96-3 | Density | N/A |
PSA | 281.59000 | LogP | -2.14560 |
Solubility | N/A | Melting Point |
N/A |
Formula | C16H20N7NaO7S3 | Boiling Point | N/A |
Molecular Weight | 541.565 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(2-amino-2-carboxyethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, [6R-[6a,7a,7(S*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[[(2S)-2-amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R,7S)- (9CI);Cefminox sodium;Cefminox sodium salt;Meicelin; |
Article Data | 1 |
l-cysteine hydrochloride
7β-chloroacetamido-7α-methoxy-3-(1-methyl-1H-tetrazole-5-mercaptomethyl)-3-cephem-4-carboxylic acid
(6R,7S)-7-[(S)-2-(2-amino-2-carboxyethylmercapto)acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Conditions | Yield |
---|---|
With ethylenediaminetetraacetic acid; sodium thiosulfate In water at 50℃; Concentration; Temperature; | 97.9% |
IUPAC Name: Sodium (6R,7S)-7-[[2-(2-amino-3-hydroxy-3-oxopropyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Systematic of Cefminox sodium (CAS NO.75498-96-3): Antibiotic MT-141 ; Meicelin ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6-alpha,7-alpha))-
CAS NO: 75498-96-3
Classification Code: Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula of Cefminox sodium (CAS NO.75498-96-3): C16H20N7NaO7S3
Molecular Weight: 541.5575
Molecular Structure:
H bond acceptors: 14
H bond donors: 5
Freely Rotating Bonds: 12
Polar Surface Area of Cefminox sodium (CAS NO.75498-96-3): 236.19 Å2
Cefminox sodium (CAS NO.75498-96-3) is used as cephalosporin antibiotic fungi.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intramuscular | 8200mg/kg (8200mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |
mouse | LD50 | intravenous | 5200mg/kg (5200mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 18, Pg. 1030, 1987. | |
rat | LD50 | intramuscular | 9600mg/kg (9600mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |
rat | LD50 | intraperitoneal | 8550mg/kg (8550mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |
rat | LD50 | intravenous | 5700mg/kg (5700mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |
rat | LD50 | oral | > 15gm/kg (15000mg/kg) | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. | |
rat | LD50 | subcutaneous | > 15gm/kg (15000mg/kg) | Japanese Journal of Antibiotics. Vol. 37, Pg. 847, 1984. |